INGALLS KERRY D. (Chief Operating Officer) purchased 2K shares of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $14.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/18/2021ACC: 0001209191-21-065673
Officer· Chief Operating Officer
Since Jul 2020
+2K
Net shares
Net buyer
$14.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2K
Price / share
$7.00
Trade value
$14K
% of position
New position
11/17/2021
0.00→2K
Total
Net shares
+2K
Net value
$14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2021 | P · Purchase | +2K | $7.00 | $14K | New position | 0.00 | 2K |
| Total | +2K | $14K | ||||||
Derivative Transactions0
No derivative transactions reported